Kelly, C. M., Shoushtari, A. N., Qin, L., D’Angelo, S. P., Dickson, M. A., Gounder, M. M., . . . Tap, W. D. (2018). A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor. Invest New Drugs.
Citação norma ChicagoKelly, Ciara M., et al. "A Phase Ib Study of BGJ398, a Pan-FGFR Kinase Inhibitor in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumor." Invest New Drugs 2018.
Citação norma MLAKelly, Ciara M., et al. "A Phase Ib Study of BGJ398, a Pan-FGFR Kinase Inhibitor in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumor." Invest New Drugs 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.